Capital Point

Venture Capital Active Tel Aviv-Yafo, Israel Est. 2000
Visit website ↗ LinkedIn
Last updated 2026-06-18
Portfolio
8
in our dataset
Rounds participated
10
Rounds led
0
Rounds' value
$104.1M
total disclosed, rounds participated
Stages
A Round, B Round, Seed

About

Capital Point is an investment company traded on the Tel Aviv Stock Exchange with a portfolio of more than 30 companies at different development stages. The company has accumulated vast experience in the process of screening, evaluating, and mentoring early-stage companies. Capital Point was originally focused on early-stage science-based companies and managed two technology incubators. In 2012, it decided to diversify its portfolio and to be more opportunity oriented, adding significant value to its portfolio to the benefit of shareholders in the short, medium, and long-range. As of today, Capital Point makes investments in the field Biomed and other life sciences technologies.

Portfolio · 8

ConTiPi Medical
Noninvasive, Disposable Vaginal Devices for Pelvic Floor Disorders
2 rounds $51.0M committed Latest: 2023-06
Visionary.ai
AI-based Image Signal Processing Solution
2 rounds $7.0M committed Latest: 2022-02
Intuition Robotics
Cognitive Digital Companion for Older Adults
1 round $36.0M committed Latest: 2020-02
Enlivex Therapeutics
Macrophage Reprogramming Cell Therapies for Life-threatening Diseases
1 round $7.0M committed Latest: 2014-05
righTune
Personalized Background Music for Websites
1 round $750K committed Latest: 2013-01
Sensegon
Psychosocial Solutions for Digital Advertising
1 round $700K committed Latest: 2011-02
Ecofer
Automated Fertigation System
1 round $650K committed Latest: 2010-07
Medasense Biometrics
Noninvasive Pain-monitoring Solutions
1 round $1.0M committed Latest: 2008-07

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences4
Business Software2
Cyber Security1
Undisclosed1
Agriculture & Food Technologies1
Automotive & Mobility Technologies1
Energy Tech1

Q&A

What is Capital Point's primary investment focus?
Capital Point primarily invests in Biomed and other life sciences technologies. The firm has a portfolio of over 30 companies at various development stages.
Can you name some of Capital Point's recent portfolio companies?
Capital Point has recently invested in Visionary.ai, an AI-based Image Signal Processing solution, and Intuition Robotics, which develops cognitive digital companions for older adults.
What is Capital Point's most notable exit?
Capital Point had a notable exit in March 2019 with Enlivex Therapeutics, which completed a reverse merger and is listed on NASDAQ.
What investment stages does Capital Point typically focus on?
Capital Point focuses on Seed, A Round, and B Round investments.
Who are the key executives at Capital Point?
Yossi Tamar serves as the CEO of Capital Point, and Ori Maor Baron is a Director.
When was Capital Point founded?
Capital Point was founded in 2000.
What is Capital Point's investment activity in the last two years?
Capital Point made an investment in February 2022 and another in June 2023, indicating continued activity in the last two years.
Which sector has seen the most investment rounds from Capital Point?
Capital Point has conducted 5 investment rounds in the Health Tech & Life Sciences sector, making it their most active sector.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)